Work

Phase I/II dose expansion of a trial investigating bendamustine and pomalidomide with dexamethasone (BPd) in patients with relapsed/refractory multiple myeloma.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.8008

Authors: Dharshan Sivaraj, Michael M. Green, Yubin Kang, David Rizzieri, Louis F. Diehl, Anne W. Beaven, Zhiguo Li, Anderson Garrett, Jackie McIntyre, Gwynn Douglas Long, Nelson Jen An Chao, Cristina Gasparetto

Institutions: Duke University, Medical University of South Carolina, Duke Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2746445311

Cites:

Cited by: 1

Related to: 10